Skip to main content
. 2022 Oct 11;9:946433. doi: 10.3389/fcvm.2022.946433

Table 2.

Significantly differentially expressed mass peaks with peptide identification by LTQ-Orbitrap-MS.

Mass, m/za FDR-adjusted p-value PE-positive (n = 30) PE-negative (n = 30) FCc Peptide ID and sequence
Mean SDb Mean SD
2026.94 1.02E-09 284.3 171.3 19.3 8.5 14.76 ITIH4: QLGLPGPPDVPDHAAYHPF
1876.85 1.33E-09 105.7 65.1 16.9 10.3 6.24 Complement C3: YSIITPNILRLESEET
3276.45 1.30E-09 152.9 59.9 34.6 22.6 4.42 FGA: SSSYSKQFTSSTSYNRGDSTFESKSYKM (+15.99)Ad
3260.46 1.23E-09 1117.7 419.9 270.3 164.9 4.14 FGA: SSSYSKQFTSSTSYNRGDSTFESKSYKMA
2192.10 1.56E-03 113.2 103.1 45.6 32.8 2.48 Complement C3: SPMYSIITPNILRLESEET
1033.40 1.62E-03 110.2 63.9 46.2 31.1 2.38 FGA: SSSYSKQFT
2051.08 5.75E-04 436.8 330.0 218.4 260.1 2.00 ITIH4: YYLQGAKIPKPEASFSPR
5900.70 1.56E-04 430.0 282.0 1065.5 718.6 0.40 FGA: SSSYSKQFTSTSYNRGDSTFESKSYKMADEAGS-EADHEGTHSTKRGHAKSRPV
a

Mass determined by LTQ-Orbitrap-MS;

b

standard deviation;

c

fold change;

d

(+15.99) indicating oxidation on the methylsulfinyl group of methionine residue. ITIH4, Inter-alpha-trypsin inhibitor heavy chain H4; FGA, Fibrinogen alpha chain.